Single answer
Is Agios Pharmaceuticals Inc (AGIO) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.76 or 75.98%
(In 16 weeks 2 days 17 hours 7 minutes and 29 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Agios Pharmaceuticals Inc is $41.50, which is $11.54 (38.52%) above the current price today's price.
Low target: $25.00 | High target: $62.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Agios Pharmaceuticals Inc a biopharmaceutical company engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology The company offers PYRUKYND mitapivat an activator of both wildtype and a variety of mutant pyruvate kinase PK enzymes for the treatment of hemolytic anemias and AG946 that is in Phase I clinical study for treating hemolytic anemias and other indications Agios Pharmaceuticals Inc was incorporated in 2007 and is headquartered in Cambridge Massachusetts
Website: https://www.agios.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.03. Cash flow to debt ratio: -9.28. Net profit margin: -764.01%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Agios Pharmaceuticals Inc is $36.8M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Agios Pharmaceuticals Inc, 2016-02-26 had a stock price of $39.71. If you invested back then, your return now would be a loss of $9.75 per share or 24.55%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.